Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial

Plus, Actinogen receives approval of its application for a UK Innovation Passport as part of the Innovative Licensing and Access Pathway (ILAP) for Xanamem in the treatment of Alzheimer's disease Enrolment in XanaCIDD phase 2a trial of cognitive impairment and depression has surpassed 90% SYDNE...

2024-04-15 20:30 917

Wound Care Plus, LLC Revolutionizes Wound Management with ARANZ Medical's Silhouette Solution

CHRISTCHURCH, New Zealand, April 15, 2024 /PRNewswire/ -- Wound Care Plus, LLC, a leading provider of mobile wound care services in the US, has announced a groundbreaking partnership with ARANZ Medical to integrate ARANZ Medical's innovative Silhouette wound assessment solution into their wound c...

2024-04-15 20:00 737

TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S CELL THERAPY PROGRAM AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING

TreeFrog Therapeutics reports on the first bioproduction of a cell therapy for Parkinson's Disease in a scalable bioreactor1 BORDEAUX, France, April 15, 2024 /PRNewswire/ -- TreeFrog Therapeutics, a cell therapy development company with its lead program in Parkinson's Disease is presenting for t...

2024-04-15 15:30 872

DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES INCORPORATION IN US WITH RESIDENCY AT JLABS @ SAN FRANCISCO

SINGAPORE, April 15, 2024 /PRNewswire/ -- Respiree announced today that it has incorporated in the US and will be incubating within Johnson & Johnson Innovation – JLABS @South San Francisco[1] from February 12, 2024. By expanding footprint within the US, Respiree aims to deepen its relationships ...

2024-04-15 14:15 843

GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA

– Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant – – World Hepatitis Alliance Supports Global Expansion of Gilead ALL4LIVER Grant by Joining Grant Review Committee – – South Korea's Association of Liver Patients and Survivors and the Taiwan re...

2024-04-15 13:06 1103

Bloomage Demonstrates Global Quality Management Excellence through On-Site Audit by Japan's PMDA

TOKYO, April 15, 2024 /PRNewswire/ -- Bloomage recently successfully completed the on-site Good Manufacturing Practice (GMP) audit conducted byJapan's Pharmaceuticals and Medical Devices Agency (PMDA). As the official regulatory agency for pharmaceuticals inJapan, the PMDA holds significant resp...

2024-04-15 08:30 972

Bloomage Demonstrates Global Quality Management Excellence through On-Site Audit by Japan's PMDA

Pioneering Cutting-Edge Technologies: High-End Medical Imaging Developer VITAL HealthCare Debuts at CMEF

SHANGHAI, April 13, 2024 /PRNewswire/ -- On Apr. 11, 2024, VITAL HealthCare, one of the 5 core business divisions of the VITAL Group, marked a stunning debut at the 89th China International Medical Equipment Fair (CMEF) inShanghai. Drawing on the Group's core competence in R&D and its wealth of t...

2024-04-13 20:00 2623

Pioneering Cutting-Edge Technologies: High-End Medical Imaging Developer VITAL HealthCare Debuts at CMEF

【2024 AACR Late Breaking Research】TransThera announces clinical data of tinengotinib to treat patients with advanced solid tumors harboring actionable FGFR1-3 alterations

NANJING, China and GAITHURSBURG, Md., April 12, 2024 /PRNewswire/ -- TransThera Sciences, a clinical-stage biopharmaceutical company focused on inventing differentiated drugs for global patients, announced the poster presentation at the 2024 American Association for Cancer Research (AACR) to disc...

2024-04-12 21:00 1616

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data

Second major trial for atrial shunt therapy demonstrates importance of patient selection TEWKSBURY, Mass., April 12, 2024 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the recent release of V-Wave's RELIEVE-HF trial data support...

2024-04-12 13:00 1196

Healthcare Revolution 2024: Largest Industry Event Moves to Drive Superior Results in Healthcare and Medical Tourism

PALM BEACH GARDENS, Fla., April 11, 2024 /PRNewswire/ -- The largest annual gathering of key stakeholders in medical travel, healthcare leaders, and self-funded employers is back this year with an exciting new move to help stakeholders achieve superior results, elevate their programs, and redefin...

2024-04-11 23:36 1516

Don't Miss Out - Join the 7th IFPA Conference: Uncovering the Broad Spectrum of Psoriatic Disease

STOCKHOLM, April 11, 2024 /PRNewswire/ -- IFPA is delighted to announce the 7th IFPA Conference set to take place fromJune 27th to June 29th, 2024, in the picturesque city ofStockholm, Sweden. This year's conference promises to be a pivotal event for experts and stakeholders in the field of psori...

2024-04-11 16:00 1273

Don't Miss Out - Join the 7th IFPA Conference: Uncovering the Broad Spectrum of Psoriatic Disease

Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan

HELSINKI, Finland, April 11, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform") today announced a strategic partnership whereby CBC Co., Ltd. ("CBC"), will utilize its extensive experience in the Japanese pharmaceutical industry to identify opportunities for Nanoform's cutting-edge nanomedici...

2024-04-11 15:38 1265

Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer

SINGAPORE and PHILADELPHIA, April 11, 2024 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnology company dedicated to developing novel medicines to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment ofDr. John Lee, MD, PhD, as its Chief Medical Office...

2024-04-11 14:59 1358

J INTS BIO, AACR 2024 - 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, showing Clinical Benefits in the Ongoing Phase 1 Study

SEOUL, South Korea, April 11, 2024 /PRNewswire/ -- J INTS BIO announced the results of its ongoing Phase 1 clinical study of JIN-A02, a 4th generation EGFR-TKI for NSCLC treatment, at the 8th April poster session of the 2024 American Cancer Research Society (AACR) Annual Meeting held inSan Diego,...

2024-04-11 14:56 1030

J INTS BIO, AACR 2024 - 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, showing Clinical Benefits in the Ongoing Phase 1 Study

CSafe unveils cutting-edge innovations to meet cold chain customer needs

The company will launch three new technologies at the upcoming LogiPharma 2024 event MONROE, Ohio, April 10, 2024 /PRNewswire/ -- CSafe, a leading active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, announces it is launching three new technol...

2024-04-10 22:50 1766

ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research

NEWARK, Del., April 10, 2024 /PRNewswire/ -- Starting in 2023, ACROBiosystems has been continuously rolling out a series of innovative organoid-related products. At a range of significant international events, including the 2024 International Organoid Summit, the Alzheimer's Research UK Conferenc...

2024-04-10 21:00 1192

3Shape Charts Sustainable Course with Release of Comprehensive Sustainability Report 2023

Highlighted in the company's latest report, 3Shape plans to inspire sustainability awareness in the dental industry through its new 5-year sustainability plan. COPENHAGEN, Denmark, April 10, 2024 /PRNewswire/ -- 3Shape, the global innovator in digital dentistry, is proud to unveil its 2023 Susta...

2024-04-10 18:29 1209

Leading the Way: Nicklaus Children's Hospital Awarded Global Healthcare Accreditation with Excellence for Pediatric Medical Travel Services

MIAMI, April 10, 2024 /PRNewswire/ -- Nicklaus Children's Hospital in Miami, Florida, proudly announces its achievement of Global Healthcare Accreditation (GHA) with Excellence for Medical Travel Services. This is Nicklaus Children's Hospital's second GHA Accreditation with Excellence, a distinct...

2024-04-10 18:00 1212

Leading the Way: Nicklaus Children's Hospital Awarded Global Healthcare Accreditation with Excellence for Pediatric Medical Travel Services

Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024

BEIJING and PARIS, April 10, 2024 /PRNewswire/ -- On March 15th, Biologics 2024 successfully concluded inLondon, with 650 pharmaceutical, biotechnology, and academic representatives and over 50 exhibitors engaging in high-level discussions on the latest innovations in biologics discovery and deve...

2024-04-10 14:19 891

Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024

ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research

TOKYO, April 10, 2024 /PRNewswire/ -- Starting in 2023, ACROBiosystems has been launching a continuous stream of innovative organoid-related products. Displaying their advancements at key global forums including the 2024 International Organoid Summit, Alzheimer's Research UK Conference 2024, and ...

2024-04-10 14:05 1469

1 2 345 6 7 ... 576